Glaxosmithkline's, Alli Embroiling Populace Nationwide
07 July, 2007
Since its grand launch in mid of June, the novel
diet drug alli is in great buzz and turns into a talk of the global
town. The first and only over-the-counter weight
loss pill is setting great scores with immense recognition and
attention.
Alli now is on the lips of everyone as it's the only OTC diet drug available to tackle large demand for obesity solutions , stated Bill Trombettta, Ph.D., professor of pharmaceutical marketing at Saint Joseph's University.
And Alli's multi-million dollar marketing campaign is one of the critical factors that shored up its good will nationwide. The campaign utilized a unique approach to target potential consumers. By being honest about the effectiveness of the pill, the campaign eventually grabbed major attention.
The usual marketing approach utilized for these types of products is to please consumers with an unrealistic weight-loss solution, elucidated Dr. Trombetta. "But GlaxoSmithKline, on the contrary, accentuated that all is not a magical pill and is only effectual when employed as part of a healthy lifestyle.
Alli, now available at major drug and vitamin stores nationwide, acts by diminishing the fat content assimilated by the body. The maker recommended a combined use of alli with a low-fat diet.
GlaxoSmithKline has also not shown hesitation to inform populace about the adverse side effects of the drug. Alli diet pill is manufactured with a warning label notifying probable gastrointestinal side effects.
But one also has to keep in mind that the maker has been criticized recently for not being open about the potential side effects that one may experience while taking alli", opined Dr. Trombetta.
